Cerebellar Ataxia Benefitted by 5-Hydroxytryptophan

Abstract

Levorotatory 5-hydroxytryptophan (10 mg/kg/day) was found to benefit patients with various inherited or acquired cerebellar ataxias in a long-term randomized, double-blind study at the Hopital Neurologique, Alexis Carrel Faculty of Medicine, Lyon, France.

Keywords

• acquired cerebellar ataxias
• postsurgical ataxia
• static cerebellar disturbances